Introduction:
Hospitalized people with diabetes (PWD) are known to have longer length of stay (LOS). This study assessed whether non-critically ill PWD have greater LOS compared to patients without diabetes and explored LOS differences based on CMS-monitored comorbidities identified from their readmission reduction program. (CMS – Centers for Medicare and Mediaid Services via CMS.gov)
Methods:
- Population: Adults admitted to non-ICU units (June 2022–October 2024)
- Classification: Diabetes status via ICD-10 codes
- Comorbidities assessed (CMS readmission reduction program):
- Acute Myocardial Infarction (AMI)
- Chronic Obstructive Pulmonary Diseases (COPD)
- Heart Failure (HF)
- Pneumonia (PN)
- Coronary Artery Bypass Graft (CABG) surgery
- Hip/Knee replacement surgery
- Statistical analysis: Independent t-test (SPSS25)
Results:
- Overall sample:
- Patients with diabetes: 18,473
- Mean age: 67.16 ± 15.49 years
- Mean weight: 89.13 ± 21.12
- Mean HbA1c: 7.1 ± 1.7
- Mean LOS: 5.93 ± 7.31 days
- Patients without diabetes: 34,896
- Mean age: 58.90 ± 16.85 years
- Mean weight: 79.46 ± 20.31
- Mean HbA1c: 5.6 ± 0.6
- Mean LOS: 5.10 ± 7.29 days
- LOS difference significant (t=12.322, p<0.01)
- Patients with diabetes: 18,473
- Comorbidity-specific LOS (Diabetes vs Non-diabetes)
Comorbidity |
Diabetes LOS (days) |
Non-diabetes LOS (days) |
t-score (df) |
Significance |
AMI |
5.98 ± 3.83 |
5.66 ± 3.71 |
1.069 |
NS |
COPD |
4.65 ± 3.79 |
4.44 ± 4.04 |
0.523 |
NS |
HF |
7.91 ± 8.13 |
5.63 ± 5.45 |
3.654 |
p<0.01 |
PN |
6.52 ± 5.95 |
6.17 ± 5.85 |
0.634 |
NS |
CABG |
10.90 ± 6.79 |
9.29 ± 7.07 |
1.483 |
NS |
Hip/Knee |
3.61 ± 3.05 |
3.50 ± 2.49 |
0.448 |
NS |
Key findings:
- PWD had significantly longer LOS overall
- HF subgroup showed significantly greater LOS for PWD
Conclusion:
PWD had significantly longer LOS compared to non-diabetes patients. In subgroup analyses of CMS-monitored comorbidities, heart failure showed a significant LOS difference whereas differences in LOS for other comorbidities including AMI, COPD, PN, CABG and Hip/Knee Replacement were not significant. Future studies will evaluate correlation between involvement of diabetes management an LOS.
ADA 2025, 20-23 June, Chicago